Concepedia

Author

Annamaria Rapisarda

National Cancer Institute

Also Known As

A RAPISARDA, A Rapisarda, A. Rapisarda, AnnaMaria Rapisarda, Annamaria Rapisarda, Rapisarda, Annamaria

92

Publications

4.6K

Citations

27

H-Index

44

Concepts

All Affiliations

National Cancer InstituteScience Applications International Corporation (United States)Center for Cancer ResearchFrederick National Laboratory for Cancer ResearchLeidos (United States)
AR

About

Annamaria Rapisarda is an author at National Cancer Institute specializing in medicine, cell biology, and inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

13

1.8K

2

Cell Biology

11

11

1.6K

3

Biochemistry

3

3

584

4

Natural Sciences

1

1

458

5

Allergy

1

1

60

Annamaria Rapisarda

×

27

Publications

3.8K

Citations

24

H-Index

YearCitations

Regulation of the Chemokine Receptor CXCR4 by Hypoxia

Tiziana Schioppa, Badarch Uranchimeg, Alessandra Saccani,

The Journal of Experimental Medicine

2003

822

Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.

Annamaria Rapisarda, Badarch Uranchimeg, Dominic A. Scudiero,

PubMed

2002

458

Human Monocytes Undergo Functional Re-programming during Sepsis Mediated by Hypoxia-Inducible Factor-1α

Irina N. Shalova, Jyue Yuan Lim, Manesh Chittezhath,

Immunity

2015

409

Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1

Annamaria Rapisarda, Badarch Uranchimeg, Olivier Sordet,

Cancer Research

2004

295

Hypoxic induction of an HIF-1α–dependent bFGF autocrine loop drives angiogenesis in human endothelial cells

Maura Calvani, Annamaria Rapisarda, Badarch Uranchimeg,

Blood

2005

227

Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts

Annamaria Rapisarda, J. Zalek, Melinda G. Hollingshead,

Cancer Research

2004

187

Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition

Annamaria Rapisarda, Melinda G. Hollingshead, Badarch Uranchimeg,

Molecular Cancer Therapeutics

2009

168

Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors

Woondong Jeong, Annamaria Rapisarda, Sook Ryun Park,

Cancer Chemotherapy and Pharmacology

2013

149

The Tryptophan Catabolite Picolinic Acid Selectively Induces the Chemokines Macrophage Inflammatory Protein-1α and -1β in Macrophages

Maria Carla Bosco, Annamaria Rapisarda, Stefano Massazza,

The Journal of Immunology

2000

114

Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1α in Advanced Solid Tumors

Shivaani Kummar, Mark Raffeld, Lamin Juwara,

Clinical Cancer Research

2011

110

Page 1